BRADFORD TALLAMY

Registrant: CENCORA, INC. · Health Issues

Advancing Emergency Preparedness through One Health Act. COVID-19 vaccine Distribution. Strengthening Americas Strategic National Stockpile Act. Essential Medicines Strategic Stockpile Act.

Registrant: CENCORA, INC. · Agriculture

Implementation of the Veterinarian Food Directive; Antimicrobial Resistance.

Registrant: CENCORA, INC. · Taxation/Internal Revenue Code

Repeal of LIFO (last in, first out).

Registrant: CENCORA, INC. · Pharmacy

H.R.471 & S. 483 legislation to prevent and reduce prescription drug abuse. H.R. 592 & S. 314, Provide for coverage under Medicare program of pharmicist services

Registrant: CENCORA, INC. · Agriculture

Implementation of the Veterinarian Food Directive; Antimicrobial Resistance.

Registrant: CENCORA, INC. · Medicare/Medicaid

H.R. 696 & S. 506 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). H.R. 1416 legislation to exclude cancer drugs from sequestration cuts. CMS Medicare Part B Drug Payment Model. H.R. 1934, The Cancer Care Payment Reform Act of 2015.

Registrant: CENCORA, INC. · Pharmacy

Legislation to provide for coverage under Medicare program of pharmacist services. Medication therapy management. S. 988 and H.R. 803, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of the Drug Quality Security Act; FDA implementation of Section 503B of the Food, Drug, and Cosmetic Act; House and Senate Agriculture, FDA, and related agency Appropriations bills; H.R. 1959, Preserving Patient Access to Compounded Medications. Prescription drug importation. H.R. 1034, Phair Pricing Act. DEA Order Clearinghouse Act (H.R. 6600, S. 3282 - 115th Congress). H.R. 1607 - Fairness to Pet Owners Act of 2019. S.724 John S. McCain Opioid Addiction Prevent Act.

Registrant: CENCORA, INC. · Medicare/Medicaid

Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Policies to exclude cancer drugs from the sequestration cuts. Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program. Medicare Part B Biosimilar Reimbursement.

Registrant: CENCORA, INC. · Agriculture

Implementation of the Veterinarian Food Directive; Antimicrobial Resistance.

Registrant: CENCORA, INC. · Pharmacy

H.R. 471 & S. 483 legislation to prevent and reduce prescription drug abuse. H.R. 592 & S. 314, Provide for coverage under Medicare program of pharmacist services. Medication Therapy Management, including S. 776 The Medication Therapy Management Empowerment Act of 2015. H.R.5951 and S. 3308, legislation to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of the Drug Quality Security Act.

Registrant: CENCORA, INC. · Medicare/Medicaid

Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program. Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B. Recognizing pharmacists as providers within Medicare for COVID-19 response. Paycheck Protection Program Flexibility Act of 2020. Paycheck Protection Program and Health Care Enhancement Act. Most Favored Nation (MFN) policy. Medicare Sequester Relief Act (H.R. 1868). American Rescue Plan.

Registrant: CENCORA, INC. · Pharmacy

S. 483 (114th Congress) legislation to prevent and reduce prescription drug abuse. H.R. 592 & S. 109, provide for coverage under Medicare program of pharmacist services. Medication Therapy Management. H.R. 1038 and S. 413, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of Drug Quality Security Act; FDA implementation of Section 503B of the Food, Drug, and Cosmetic Act; House & Senate Agriculture, FDA & Related Agency Appropriations bills; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017. Prescription Drug Importation including S. 771 and H.R. 1776, the Improving Access to Affordable Prescription Drugs Act and S.469, the Affordable and Safe Prescription Drug Importation Act. E-Prescribing bills including H.R. 3528 and S. 2460, the Every Prescription Conveyed Securely (EPCS) Act. H.R. 5958, Phair Pricing Act of 2018. HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. S. 3282 and H.R. 6600, the DEA Order Clearinghouse Act of 2018.

Registrant: CENCORA, INC. · Pharmacy

Legislation to provide for coverage under Medicare program of pharmacist services. Medication therapy management. S. 988 and H.R. 803, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of the Drug Quality Security Act; FDA implementation of Section 503B of the Food, Drug, and Cosmetic Act; House and Senate Agriculture, FDA, and related agency Appropriations bills; H.R. 1959, Preserving Patient Access to Compounded Medications. Prescription drug importation. H.R. 1034 and S. 640, Phair Pricing Act. DEA Order Clearinghouse Act (H.R. 6600, S. 3282 - 115th Congress). H.R. 1607 - Fairness to Pet Owners Act of 2019. S.724 and H.R. 1614 John S. McCain Opioid Addiction Prevent Act. Issues related to drug shortages. Coronavirus Aid, Relief and Economic Security Act (CARES Act)

Registrant: CENCORA, INC. · Pharmacy

S. 483 (114th Congress) legislation to prevent and reduce prescription drug abuse. H.R. 592 & S. 109, provide for coverage under Medicare program of pharmacist services. Medication Therapy Management. H.R. 1038 and S. 413, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of Drug Quality Security Act; FDA implementation of Section 503B of the Food, Drug, and Cosmetic Act; House & Senate Agriculture, FDA & Related Agency Appropriations bills; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017. Prescription Drug Importation including S. 771 and H.R. 1776, the Improving Access to Affordable Prescription Drugs Act and S.469, the Affordable and Safe Prescription Drug Importation Act. E-Prescribing bills including H.R. 3528 and S. 2460, the Every Prescription Conveyed Securely (EPCS) Act.

Registrant: CENCORA, INC. · Health Issues

Advancing Emergency Preparedness through One Health Act. COVID-19 vaccine Distribution. Strengthening Americas Strategic National Stockpile Act.

Registrant: CENCORA, INC. · Health Issues

Advancing Emergency Preparedness through One Health Act. The Consolidated Appropriations Act of 2021 (H.R. 133). COVID-19 vaccine distribution

Registrant: CENCORA, INC. · Pharmacy

Legislation to provide for coverage under Medicare program of pharmacist services. Medication therapy management. S. 988 and H.R. 803, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of the Drug Quality Security Act; FDA implementation of Section 503B of the Food, Drug, and Cosmetic Act; House and Senate Agriculture, FDA, and related agency Appropriations bills; H.R. 1959, Preserving Patient Access to Compounded Medications. Prescription drug importation. H.R. 1034 and S. 640, Phair Pricing Act. DEA Order Clearinghouse Act (H.R. 6600, S. 3282 - 115th Congress). H.R. 1607 - Fairness to Pet Owners Act of 2019. S.724 and H.R. 1614 John S. McCain Opioid Addiction Prevent Act. Issues related to drug shortages. Coronavirus Aid, Relief and Economic Security Act (CARES Act). Recognizing pharmacists as providers within Medicare for COVID-19 response. Paycheck Protection Program Flexibility Act of 2020. Paycheck Protection Program and Health Care Enhancement Act

Registrant: CENCORA, INC. · Pharmacy

H.R.471 & S. 483 legislation to prevent and reduce prescription drug abuse. H.R. 592 & S. 314, Provide for coverage under Medicare program of pharmicist services

Registrant: CENCORA, INC. · Medicare/Medicaid

H.R. 1920 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). Policies to exclude cancer drugs from the sequestration cuts. H.R. 1834 & S. 463, The Cancer Care Payment Reform Act of 2017. CMS, OMB, HHS, White House Domestic Policy Council, Medicare Part B Reimbursement, Medicare Part D Pharmacy Reimbursement.

Registrant: CENCORA, INC. · Pharmacy

S. 483 (114th Congress) legislation to prevent and reduce prescription drug abuse. H.R. 592 & S. 109, provide for coverage under Medicare program of pharmacist services. Medication Therapy Management H.R. 10385 and S. 413, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of Drug Quality Security Act; FDA implementation of Section 503B of the Food, Drug, and Cosmetic Act; House & Senate Agriculture, FDA & Related Agency Appropriations bills; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017. Prescription Drug Importation including S. 771 and H.R. 1776, the Improving Access to Affordable Prescription Drugs Act and S.469, the Affordable and Safe Prescription Drug Importation Act S. 413 and H.R. 1038 Medicare Part D and Pharmacy Reimbursement.

Registrant: CENCORA, INC. · Medicare/Medicaid

H.R. 1920 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). Policies to exclude cancer drugs from the sequestration cuts. H.R. 1834 & S. 463, The Cancer Care Payment Reform Act of 2017. CMS, OMB, HHS, White House Domestic Policy Council, Medicare Part B Reimbursement, Medicare Part D Pharmacy Reimbursement.

Registrant: CENCORA, INC. · Agriculture

Implementation of the Veterinarian Food Directive; Antimicrobial Resistance.

Registrant: CENCORA, INC. · Medicare/Medicaid

H.R. 696 & S. 506 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). H.R. 1416 legislation to exclude cancer drugs from sequestration cuts. CMS Medicare Part B Drug Payment Model. H.R. 1934, The Cancer Care Payment Reform Act of 2015.

Registrant: CENCORA, INC. · Taxation/Internal Revenue Code

Repeal of LIFO (last in, first out).

Registrant: CENCORA, INC. · Health Issues

Advancing Emergency Preparedness through One Health Act

Registrant: CENCORA, INC. · Pharmacy

H.R.471 & S. 483 legislation to prevent and reduce prescription drug abuse. H.R. 592 & S. 314, Provide for coverage under Medicare program of pharmicist services

Registrant: CENCORA, INC. · Taxation/Internal Revenue Code

Repeal of LIFO (last in, first out).

Registrant: CENCORA, INC. · Pharmacy

H.R.471 & S. 483 legislation to prevent and reduce prescription drug abuse. H.R. 592 & S. 314, Provide for coverage under Medicare program of pharmacist services. Medication Therapy Management, including S. 776 The Medication Therapy Management Empowerment Act of 2015.

Registrant: CENCORA, INC. · Medicare/Medicaid

H.R. 696 & S. 506 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). H.R. 1416 legislation to exclude cancer drugs from sequestration cuts.

Registrant: CENCORA, INC. · Pharmacy

H.R.471 & S. 483 legislation to prevent and reduce prescription drug abuse. H.R. 592 & S. 314, Provide for coverage under Medicare program of pharmicist services

Registrant: CENCORA, INC. · Agriculture

Implementation of the Veterinarian Food Directive; Antimicrobial Resistance.

Registrant: CENCORA, INC. · Taxation/Internal Revenue Code

Repeal of LIFO (last in, first out).

Registrant: CENCORA, INC. · Taxation/Internal Revenue Code

Repeal of LIFO (last in, first out).

Registrant: CENCORA, INC. · Pharmacy

S. 483 (114th Congress) legislation to prevent and reduce prescription drug abuse. H.R. 592 & S. 109, provide for coverage under Medicare program of pharmacist services. Medication Therapy Management. H.R. 1038 and S. 413, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of Drug Quality Security Act; FDA implementation of Section 503B of the Food, Drug, and Cosmetic Act; House & Senate Agriculture, FDA & Related Agency Appropriations bills; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017. Prescription Drug Importation including S. 771 and H.R. 1776, the Improving Access to Affordable Prescription Drugs Act and S.469, the Affordable and Safe Prescription Drug Importation Act. E-Prescribing bills including H.R. 3528 and S. 2460, the Every Prescription Conveyed Securely (EPCS) Act. H.R. 5958, Phair Pricing Act of 2018. HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. S. 3282 and H.R. 6600, the DEA Order Clearinghouse Act of 2018. H.R. 6, SUPPORT for Patients and Communities Act.

Registrant: CENCORA, INC. · Medicare/Medicaid

H.R. 1920 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) generally (in the context of Deficit Reduction). Policies to exclude cancer drugs from the sequestration cuts. Removal Of Safe Harbor Protection for Rebates to Plans or PBMs Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection. International Pricing Index Model. Competitive Acquisition Program.

Registrant: CENCORA, INC. · Medicare/Medicaid

Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Policies to exclude cancer drugs from the sequestration cuts. Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program.

Registrant: CENCORA, INC. · Agriculture

Implementation of the Veterinarian Food Directive; Antimicrobial Resistance.

Registrant: CENCORA, INC. · Medicare/Medicaid

H.R. 696 & S. 506 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). H.R. 1416 legislation to exclude cancer drugs from sequestration cuts. H.R. 1934, The Cancer Care Payment Reform Act of 2015. H.R.5122 - To prohibit further action on the proposed Medicare Part B Provider Reimbursement Demonstration Project through CMS/CMMI, Medicare Access and CHIP Reauthorization Act (MACRA) implementation.

Registrant: CENCORA, INC. · Medicare/Medicaid

H.R. 1920 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). Policies to exclude cancer drugs from the sequestration cuts.

Registrant: CENCORA, INC. · Taxation/Internal Revenue Code

Repeal of LIFO (last in, first out).

Registrant: CENCORA, INC. · Taxation/Internal Revenue Code

Repeal of LIFO (last in, first out).

Registrant: CENCORA, INC. · Pharmacy

S. 483 (114th Congress) legislation to prevent and reduce prescription drug abuse. H.R. 592 & S. 109, provide for coverage under Medicare program of pharmacist services. Medication Therapy Management. H.R. 1038 and S. 413, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of Drug Quality Security Act; FDA implementation of Section 503B of the Food, Drug, and Cosmetic Act; House & Senate Agriculture, FDA & Related Agency Appropriations bills; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017. Prescription Drug Importation including S. 771 and H.R. 1776, the Improving Access to Affordable Prescription Drugs Act and S.469, the Affordable and Safe Prescription Drug Importation Act. E-Prescribing bills including H.R. 3528 and S. 2460, the Every Prescription Conveyed Securely (EPCS) Act. H.R. 5958, Phair Pricing Act of 2018. HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.

Registrant: CENCORA, INC. · Taxation/Internal Revenue Code

Repeal of LIFO (last in, first out).

Registrant: CENCORA, INC. · Pharmacy

Legislation to provide for coverage under Medicare program of pharmacist services. Medication therapy management. S. 988 and H.R. 803, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of the Drug Quality Security Act; FDA implementation of Section 503B of the Food, Drug, and Cosmetic Act; House and Senate Agriculture, FDA, and related agency Appropriations bills; H.R. 1959, Preserving Patient Access to Compounded Medications. Prescription drug importation. H.R. 1034, Phair Pricing Act. DEA Order Clearinghouse Act (H.R. 6600, S. 3282 - 115th Congress). H.R. 1607 - Fairness to Pet Owners Act of 2019.

Registrant: CENCORA, INC. · Pharmacy

H.R. 471 & S. 483 legislation to prevent and reduce prescription drug abuse. H.R. 592 & S. 314, Provide for coverage under Medicare program of pharmacist services. Medication Therapy Management, including S. 776 The Medication Therapy Management Empowerment Act of 2015. H.R.5951 and S. 3308, legislation to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of the Drug Quality Security Act.

Registrant: CENCORA, INC. · Pharmacy

H.R.471 & S. 483 legislation to prevent and reduce prescription drug abuse. H.R. 592 & S. 314, Provide for coverage under Medicare program of pharmacist services. Medication Therapy Management, including S. 776 The Medication Therapy Management Empowerment Act of 2015.

Registrant: CENCORA, INC. · Medicare/Medicaid

H.R. 696 & S. 506 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). H.R. 1416 legislation to exclude cancer drugs from sequestration cuts. H.R. 1934, The Cancer Care Payment Reform Act of 2015. H.R.5122 - To prohibit further action on the proposed Medicare Part B Provider Reimbursement Demonstration Project through CMS/CMMI, Medicare Access and CHIP Reauthorization Act (MACRA) implementation.

Registrant: CENCORA, INC. · Medicare/Medicaid

Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Policies to exclude cancer drugs from the sequestration cuts. Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program. S. 2543 The Prescription Drug Pricing Reduction Act of 2019. Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B. Coronavirus Aid, Relief and Economic Security Act (CARES Act). Recognizing pharmacists as providers within Medicare for COVID-19 response. Paycheck Protection Program Flexibility Act of 2020. Paycheck Protection Program and Health Care Enhancement Act

Registrant: CENCORA, INC. · Pharmacy

Legislation to provide for coverage under Medicare program of pharmacist services. Medication therapy management. S. 988 and H.R. 803, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. House and Senate Agriculture, FDA, and related agency Appropriations bills. Prescription drug importation. H.R. 1034 and S. 640, Phair Pricing Act. DEA Order Clearinghouse Act (H.R. 6600, S. 3282 - 115th Congress). H.R. 1607 - Fairness to Pet Owners Act of 2019. S.724 and H.R. 1614 John S. McCain Opioid Addiction Prevent Act. Issues related to drug shortages. Coronavirus Aid, Relief and Economic Security Act (CARES Act). Recognizing pharmacists as providers within Medicare for COVID-19 response. Paycheck Protection Program Flexibility Act of 2020. Paycheck Protection Program and Health Care Enhancement Act

Registrant: CENCORA, INC. · Medicare/Medicaid

Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Policies to exclude cancer drugs from the sequestration cuts. Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program. S. 2543 The Prescription Drug Pricing Reduction Act of 2019. Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B. Coronavirus Aid, Relief and Economic Security Act (CARES Act). Recognizing pharmacists as providers within Medicare for COVID-19 response. Paycheck Protection Program Flexibility Act of 2020. Paycheck Protection Program and Health Care Enhancement Act. Most Favored Nation (MFN) policy. Extension of Medicare sequestration relief.

Registrant: CENCORA, INC. · Pharmacy

Legislation to provide for coverage under Medicare program of pharmacist services. Medication therapy management. S. 988 and H.R. 803, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. House and Senate Agriculture, FDA, and related agency Appropriations bills. Prescription drug importation. H.R. 1034 and S. 640, Phair Pricing Act. DEA Order Clearinghouse Act (H.R. 6600, S. 3282 - 115th Congress). H.R. 1607 - Fairness to Pet Owners Act of 2019. S.724 and H.R. 1614 John S. McCain Opioid Addiction Prevent Act. Issues related to drug shortages. Coronavirus Aid, Relief and Economic Security Act (CARES Act). Recognizing pharmacists as providers within Medicare for COVID-19 response. Paycheck Protection Program Flexibility Act of 2020. Paycheck Protection Program and Health Care Enhancement Act

Registrant: CENCORA, INC. · Pharmacy

Legislation to provide for coverage under Medicare program of pharmacist services. Medication therapy management. Legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. House and Senate Agriculture, FDA, and related agency Appropriations bills. Prescription drug importation. Phair Pricing Act. DEA Order Clearinghouse Act John S. McCain Opioid Addiction Prevent Act. Issues and policies related to generic drug shortages. Recognizing pharmacists as providers within Medicare for COVID-19 response. Paycheck Protection Program Flexibility Act of 2020. Paycheck Protection Program and Health Care Enhancement Act. Federal Retail Pharmacy Partnership for COVID-19 vaccine. American Rescue Plan. Permanent Extension of PREP Act Declarations.

Registrant: CENCORA, INC. · Medicare/Medicaid

Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program. Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B. Recognizing pharmacists as providers within Medicare for COVID-19 response. Paycheck Protection Program and Health Care Enhancement Act. Most Favored Nation (MFN) policy. Medicare Sequester Relief Act (H.R. 1868). American Rescue Plan. The Bolstering Innovative Options to Save Immediately on Medicines (BIOSIM) Act (H.R. 2815).

Registrant: CENCORA, INC. · Pharmacy

Legislation to provide for coverage under Medicare program of pharmacist services. Pharmacy and Medically Underserved Area Enhancement Act. Medication therapy management. Legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. House and Senate Agriculture, FDA, and related agency Appropriations bills. Prescription drug importation. Phair Pricing Act. Pharmacy DIR Reform To Reduce Senior Drug Costs Act. DEA Order Clearinghouse Act. John S. McCain Opioid Addiction Prevent Act. Issues and policies related to generic drug shortages. Recognizing pharmacists as providers within Medicare for COVID-19 response. Paycheck Protection Program and Health Care Enhancement Act. Federal Retail Pharmacy Partnership for COVID-19 vaccine. American Rescue Plan. Permanent Extension of PREP Act Declarations. The Ensuring Seniors Access to Local Pharmacies Act.

Registrant: CENCORA, INC. · Medicare/Medicaid

H.R. 696 & S. 506 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). H.R. 1416 legislation to exclude cancer drugs from sequestration cuts.

Registrant: CENCORA, INC. · Medicare/Medicaid

H.R. 1920 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). Policies to exclude cancer drugs from the sequestration cuts.

Registrant: CENCORA, INC. · Agriculture

Implementation of the Veterinarian Food Directive; Antimicrobial Resistance.

Registrant: CENCORA, INC. · Health Issues

Advancing Emergency Preparedness through One Health Act

Registrant: CENCORA, INC. · Health Issues

Advancing Emergency Preparedness through One Health Act. COVID-19 vaccine Distribution. Strengthening Americas Strategic National Stockpile Act. Essential Medicines Strategic Stockpile Act.

Registrant: CENCORA, INC. · Taxation/Internal Revenue Code

Repeal of LIFO (last in, first out).

Registrant: CENCORA, INC. · Medicare/Medicaid

Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Policies to exclude cancer drugs from the sequestration cuts. Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program. S. 2543 The Prescription Drug Pricing Reduction Act of 2019. Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B. Coronavirus Aid, Relief and Economic Security Act (CARES Act)

Registrant: CENCORA, INC. · Medicare/Medicaid

Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Policies to exclude cancer drugs from the sequestration cuts. Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program. S. 2543 The Prescription Drug Pricing Reduction Act of 2019. Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B.

Registrant: CENCORA, INC. · Pharmacy

Legislation to provide for coverage under Medicare program of pharmacist services. Medication therapy management. S. 988 and H.R. 803, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of the Drug Quality Security Act; FDA implementation of Section 503B of the Food, Drug, and Cosmetic Act; House and Senate Agriculture, FDA, and related agency Appropriations bills; H.R. 1959, Preserving Patient Access to Compounded Medications. Prescription drug importation. H.R. 1034 and S. 640, Phair Pricing Act. DEA Order Clearinghouse Act (H.R. 6600, S. 3282 - 115th Congress). H.R. 1607 - Fairness to Pet Owners Act of 2019. S.724 and H.R. 1614 John S. McCain Opioid Addiction Prevent Act.

Registrant: CENCORA, INC. · Medicare/Medicaid

H.R. 696 & S. 506 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). H.R. 1416 legislation to exclude cancer drugs from sequestration cuts.

Registrant: CENCORA, INC. · Agriculture

Implementation of the Veterinarian Food Directive; Antimicrobial Resistance.

Registrant: CENCORA, INC. · Medicare/Medicaid

H.R. 696 & S. 506 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). H.R. 1416 legislation to exclude cancer drugs from sequestration cuts.

Registrant: CENCORA, INC. · Medicare/Medicaid

Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Policies to exclude cancer drugs from the sequestration cuts. Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program. S. 2543 The Prescription Drug Pricing Reduction Act of 2019. Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B. Coronavirus Aid, Relief and Economic Security Act (CARES Act). Recognizing pharmacists as providers within Medicare for COVID-19 response. Paycheck Protection Program Flexibility Act of 2020. Paycheck Protection Program and Health Care Enhancement Act

Registrant: CENCORA, INC. · Taxation/Internal Revenue Code

Repeal of LIFO (last in, first out).

Registrant: CENCORA, INC. · Medicare/Medicaid

H.R. 1920 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). Policies to exclude cancer drugs from the sequestration cuts.

Registrant: CENCORA, INC. · Medicare/Medicaid

Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Policies to exclude cancer drugs from the sequestration cuts. Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program. S. 2543 The Prescription Drug Pricing Reduction Act of 2019. Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B.

Registrant: CENCORA, INC. · Pharmacy

Legislation to provide for coverage under Medicare program of pharmacist services. Medication therapy management. S. 988 and H.R. 803, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of the Drug Quality Security Act; FDA implementation of Section 503B of the Food, Drug, and Cosmetic Act; House and Senate Agriculture, FDA, and related agency Appropriations bills; H.R. 1959, Preserving Patient Access to Compounded Medications. Prescription drug importation. H.R. 1034 and S. 640, Phair Pricing Act. DEA Order Clearinghouse Act (H.R. 6600, S. 3282 - 115th Congress). H.R. 1607 - Fairness to Pet Owners Act of 2019. S.724 and H.R. 1614 John S. McCain Opioid Addiction Prevent Act.

Registrant: CENCORA, INC. · Medicare/Medicaid

Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program. Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B. Recognizing pharmacists as providers within Medicare for COVID-19 response. Paycheck Protection Program and Health Care Enhancement Act. Most Favored Nation (MFN) policy. Medicare Sequester Relief Act (H.R. 1868). American Rescue Plan. The Bolstering Innovative Options to Save Immediately on Medicines (BIOSIM) Act (H.R. 2815).

Registrant: CENCORA, INC. · Taxation/Internal Revenue Code

Repeal of LIFO (last in, first out).

Registrant: CENCORA, INC. · Medicare/Medicaid

H.R. 1920 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). Policies to exclude cancer drugs from the sequestration cuts. H.R. 1834 & S. 463, The Cancer Care Payment Reform Act of 2017.

Registrant: CENCORA, INC. · Pharmacy

Enactment of S.483 (114th Congress)legislation to prevent and reduce prescription drug abuse. H.R. 592 & S. 109, Provide for coverage under Medicare program of pharmacist services. Medication Therapy Management H.R. 1038 and S. 413, legislation to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of the Drug Quality Security Act Prescription Drug Importation including S.771 & H.R. 1776, the Improving Access to Affordable Prescription Drugs Act and S. 469, the Affordable and Safe Prescription Drug Importation Act. S. 413 and H.R. 1038 Medicare Part D and Pharmacy Reimbursement.

Registrant: CENCORA, INC. · Pharmacy

Enactment of S.483 (114th Congress)legislation to prevent and reduce prescription drug abuse. H.R. 592 & S. 109, Provide for coverage under Medicare program of pharmacist services. Medication Therapy Management H.R. 1038 and S. 413, legislation to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of the Drug Quality Security Act Prescription Drug Importation including S.771 & H.R. 1776, the Improving Access to Affordable Prescription Drugs Act and S. 469, the Affordable and Safe Prescription Drug Importation Act.

Registrant: CENCORA, INC. · Taxation/Internal Revenue Code

Preservation of LIFO (last in, first out).

Registrant: CENCORA, INC. · Pharmacy

Enactment of S. 483 (114th Congress) legislation to prevent and reduce prescription drug abuse. H.R. 592 & S. 109, provide for coverage under Medicare program of pharmacist services. Medication Therapy Management H.R. 10385 and S. 413, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of Drug Quality Security Act; FDA implementation of Section 503B of the Food, Drug, and Cosmetic Act; House & Senate Agriculture, FDA & Related Agency Appropriations bills; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017. Prescription Drug Importation including S. 771 and H.R. 1776, the Improving Access to Affordable Prescription Drugs Act and S.469, the Affordable and Safe Prescription Drug Importation Act S. 413 and H.R. 1038 Medicare Part D and Pharmacy Reimbursement.

Registrant: CENCORA, INC. · Medicare/Medicaid

H.R. 1920 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). Policies to exclude cancer drugs from the sequestration cuts.